This article needs more reliable medical references for verification or relies too heavily on primary sources. (January 2023) |
Part of a series on the |
COVID-19 pandemic |
---|
|
COVID-19 portal |
COVID-19 vaccine clinical research uses clinical research to establish the characteristics of COVID-19 vaccines. These characteristics include efficacy, effectiveness, and safety. As of November 2022[update], 40 vaccines are authorized by at least one national regulatory authority for public use:[1][2]
As of June 2022[update], 353 vaccine candidates are in various stages of development, with 135 in clinical research, including 38 in phase I trials, 32 in phase I–II trials, 39 in phase III trials, and 9 in phase IV development.[1]
Hotez
was invoked but never defined (see the help page).